Literature DB >> 17851659

Transcriptional profile induced by furazolidone treatment of Shigella flexneri.

Hua Fu1, Wenchuan Leng, Jing Wang, Wenliang Zhang, Junping Peng, Lingling Wang, Qi Jin.   

Abstract

Shigella flexneri is a facultative intracellular pathogen responsible for endemic shigellosis especially in developing countries. Furazolidone, a nitrofuran derivative, is very effective against the infection with S. flexneri. To examine potential effects of furazolidone on this germ, a whole-genome DNA microarray was constructed and transcriptional profiles of the responses to furazolidone were determined. The expressing data revealed adaptive responses of S. flexneri to oxidative stress induced by furazolidone treatment. Iron metabolism was found to be disturbed by furazolidone through derepression of the iron uptake regulon. In addition, energy metabolism, amino acid metabolism, cofactors metabolism, and DNA repair system were also affected by the drug. These data establish a potential for furazolidone to enhance free radical reactions through reductive activation by oxygen-sensitive nitroreductase. Moreover, we provide evidence that furazolidone is able to cause metabolic dysfunction, which cannot always be attributed to oxidative stress, and interactions between reductive metabolites of furazolidone and S. flexneri should be considered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17851659     DOI: 10.1007/s00253-007-1180-9

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  5 in total

1.  Common changes in global gene expression induced by RNA polymerase inhibitors in Shigella flexneri.

Authors:  Hua Fu; Liguo Liu; Xiaobing Zhang; Yafang Zhu; Lina Zhao; Junping Peng; Hongxuan He; Qi Jin
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

2.  Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine.

Authors:  Yan Wang; Qian Tong; Jia-Wen Shou; Zhen-Xiong Zhao; Xiao-Yang Li; Xian-Feng Zhang; Shu-Rong Ma; Chi-Yu He; Yuan Lin; Bao-Ying Wen; Fang Guo; Jie Fu; Jian-Dong Jiang
Journal:  Theranostics       Date:  2017-06-24       Impact factor: 11.556

3.  Correlated Transcriptional Responses Provide Insights into the Synergy Mechanisms of the Furazolidone, Vancomycin, and Sodium Deoxycholate Triple Combination in Escherichia coli.

Authors:  Catrina Olivera; Murray P Cox; Gareth J Rowlands; Jasna Rakonjac
Journal:  mSphere       Date:  2021-09-08       Impact factor: 4.389

Review 4.  The mechanism of berberine alleviating metabolic disorder based on gut microbiome.

Authors:  Han Wang; Haiyu Zhang; Zezheng Gao; Qiqi Zhang; Chengjuan Gu
Journal:  Front Cell Infect Microbiol       Date:  2022-08-25       Impact factor: 6.073

5.  Gut Microbiota-Regulated Pharmacokinetics of Berberine and Active Metabolites in Beagle Dogs After Oral Administration.

Authors:  Ru Feng; Zhen-Xiong Zhao; Shu-Rong Ma; Fang Guo; Yan Wang; Jian-Dong Jiang
Journal:  Front Pharmacol       Date:  2018-03-21       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.